In vitro deprivation of CD8+CD57+T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome

Experimental Hematology

Volumn 38, Issue 8, 2010, Pages 677-684

  Zheng, Zhang ^a   Qianqiao, Zhang ^a   Qi, He ^a   Feng, Xu ^a   Chunkang, Chang ^a   Xiao, Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL POLARITY; CHILD; COCULTURE; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; VOLUNTEER;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD57; BONE MARROW CELLS; CELL PROLIFERATION; CHILD; CHROMOSOME ABERRATIONS; COCULTURE TECHNIQUES; FEMALE; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASTIC STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 77954536742     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.04.002     Document Type: Article

References (20)

1. Koike M., Ishiyama T., Tomoyasu S., et al. Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. Leuk Res 1995, 19:639-644.
2. Kitagawa M., Saito I., Kuwata T., et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (INF)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997, 11:2049-2054.
3. Verhoef G.E., Schouwer P., Ceuppens J.L., et al. Measurement of serum cytokine levels in patients with myelodysplastic syndrome. Leukemia 1992, 6:1268-1272.
4. Molldrem J., Jiang Y.Z., Stetler-Stevenson M., et al. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 1998, 102:148-155.
5. Kook H., Zeng W., Guibin C., et al. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol 2001, 29:1270-1277.
6. Matsutani T., Yoshioka T., Tsuruta Y., et al. Determination of T cell receptors of clonal CD8 positive T cells in myelodysplastic syndrome with erythroidhypoplasia. Leuk Res 2003, 27:305-312.
7. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
8. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100:2292-2302.
9. Gonzalez Garcia J.R., Meza-Espinoza J.P. Use of the International System for Human Cytogenetic Nomenclature (ISCN). Blood 2006, 108:3952-3953.
10. Tarazona R., DelaRosa O., Alonso C., et al. Increased expression of NKcell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 2000, 121:77-88.
11. + T cells closely correlates with CD56 surface expression. J Immunol 2000, 164:1148-1152.
12. Baumann I., Scheid C., Koref M.S., et al. Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome. Exp Hematol 2002, 30:1405-1411.
13. Sloand E.M., Mainwaring L., Fuhrer M., et al. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 2005, 106:841-851.
14. Sloand E., Kim S., Maciejewski J.P., et al. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 2002, 100:1185-1191.
15. Wu L., Li X., Chang C., et al. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome. Int J Lab Hematol 2002, 30:390-399.
16. Zang D.Y., Goodwin R.G., Loken M.R., et al. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 2001, 98:3058-3065.
17. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
18. Meers S., Vandenberghe P., Boogaerts, et al. The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patients. Leuk Res 2008, 32:1026-1035.
19. Sloand E.M., Kim S., Fuhrer M., et al. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood 2002, 100:4427-4432.
20. Sloand E.M., Pfannes L., Chen G., et al. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins. Blood 2007, 109:2399-2405.